Organization · Venture Capital
Brightlands Venture Partners
Brightlands Venture Partners (BVP) is a Dutch venture capital firm that invests in early-stage companies focused on innovative solutions in health, agrifood, and renewable chemistry. They leverage their extensive network and sector expertise to support startups addressing complex societal challenges.
Overview
What Brightlands Venture Partners does
What Brightlands Venture Partners is
Brightlands Venture Partners (BVP) is a Dutch venture capital firm that invests in early-stage companies focused on innovative solutions in health, agrifood, and renewable chemistry. They leverage their extensive network and sector expertise to support startups addressing complex societal challenges.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2004
- Approximate age
- About 22 years
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find Brightlands Venture Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Brightlands Venture Partners as a funder
Investment thesis
Brightlands Venture Partners focuses on investing in innovative companies that address global structural challenges in essential societal systems, particularly in health, agrifood, and renewable chemistry.
Focus narrative
BVP invests in breakthrough technologies with proprietary foundations that have the potential to fundamentally improve essential systems. The organization targets innovative solutions that address root causes, demonstrate technical defensibility, and are designed for real-world application, particularly in complex or regulated environments. BVP primarily invests in Seed to Series A stages, with initial ticket sizes ranging from €250,000 to €2 million.
Value beyond capital
BVP provides access to a robust ecosystem of applied research and commercialization through its connections with Brightlands innovation campuses, enhancing the potential for portfolio companies to succeed in their respective markets.
Terms and economics
- Typical check
- $250,000–$2,000,000
Focus and fit
- Stages
- Seed · Series A
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 12
Portfolio context
Notable portfolio companies include Fortimedix Surgical, Qorium, Kipster, Vivalyx, ReSolved Technologies, Psylaris, PL BioScience, Grassa, Circularise, Corporis Medical, S&dB, and EnzyPep. These companies are involved in shaping the future of health, agrifood, and renewable chemistry.
Common questions
What to know about Brightlands Venture Partners
Upseed classifies Brightlands Venture Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.